TheChek News Flow

>>> Up

* ABB Raised to Buy at Bank Vontobel; PT 40 Swiss francs (+)

* Atea Raised to Buy at Carnegie; PT 192 kroner

* CRH PT Raised to 56 euros from 53 euros at Deutsche Bank

* Deliveroo Raised to Overweight at JPMorgan; PT 392 pence

* Diageo Raised to Hold at Investec; PT 3,800 pence (+)

* Heba Fastighets Raised to Buy at Handelsbanken; PT 185 kronor

* Hochschild Mining Raised to Overweight at Barclays; PT 165 pence

* Just Eat Takeaway Raised to Overweight at JPMorgan
* Land Sec. Raised to Outperform at Exane; PT 850 pence

* Stendorren Fastigheter Raised to Buy at Handelsbanken

>>> Down

* Aareal Bank Cut to Sell at Nord/LB; PT 29 euros

* BIC Cut to Neutral at Oddo BHF; PT 55.50 euros

* Lundin Energy Cut to Reduce at Kepler Cheuvreux; PT 310 kronor
* Marimekko Cut to Hold at Carnegie; PT 95 euros

* Nordstrom Cut to Hold at Jefferies; PT $30
* Orn Software Cut to Hold at Pareto Securities; PT 10.50 kroner

* YIT Cut to Reduce at Inderes; PT 5 euros

>>> Initiation

* Bachem Rated New Hold at Kepler Cheuvreux; PT 708 Swiss francs
* BCP Rated New Outperform at Oddo BHF; PT 22 euro cents

* Ipsen Rated New Hold at Berenberg; PT 93 euros

* Lundbeck Rated New Buy at Berenberg; PT 212 kroner

* McPhy Rated New Buy at Liberum; PT 31.30 euros

* Nel Rated New Buy at Liberum; PT 23.10 kroner

* Ovh Groupe SAS Rated New Equal-Weight at Morgan Stanley

* Ovh Groupe SAS Rated New Buy at Citi; PT 28 euros

* Ovh Groupe SAS Rated New Neutral at Goldman; PT 24 euros

* Ovh Groupe SAS Rated New Overweight at JPMorgan; PT 25 euros

* Siegfried Rated New Buy at Kepler Cheuvreux

* Vifor Pharma Rated New Hold at Berenberg; PT 116 Swiss francs

>>> Call

* BBVA Shares May Lag as Lira Volatility Bites: Morgan Stanley (+)

* Elior FY22 Guidance Soft, Longer-Term Outlook Strong: Bernstein (+)

* Hochschild Mining Selloff Presents an Opportunity, Barclays Says (+)

* ITM Power, McPhy, Nel Buys at Liberum on Strong Demand Outlook
* SMA Solar Downgraded at Berenberg Amid Cautious Outlook for 2022

* UCB, Lundbeck Are Berenberg’s Mid-Cap Pharma Picks, Ipsen Hold